Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique
Gregg W. Stone, Dean J. Kereiakes, Tommaso Gori, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 3, pp. 183-195
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Prognostic Value of Postpercutaneous Coronary Intervention Murray-Law-Based Quantitative Flow Ratio
Daixin Ding, Jinlong Zhang, Peng Wu, et al.
JACC Asia (2025) Vol. 5, Iss. 1, pp. 59-70
Open Access | Times Cited: 1
A Randomized Comparison of Bioheart Sirolimus-Eluting Bioresorbable Scaffold and Everolimus-Eluting Stents
Shengwen Liu, Shaoping Nie, Yuqing Hou, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2025) Vol. 18, Iss. 1, pp. 15-27
Closed Access | Times Cited: 1
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold
David Power, Anton Camaj, Dean J. Kereiakes, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2025) Vol. 18, Iss. 1, pp. 1-11
Closed Access | Times Cited: 1
Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?
Simone Fezzi, Daixin Ding, Felix Mahfoud, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 9, pp. 652-662
Closed Access | Times Cited: 11
Bioadaptor implant versus contemporary drug-eluting stent in percutaneous coronary interventions in Sweden (INFINITY-SWEDEHEART): a single-blind, non-inferiority, registry-based, randomised controlled trial
David Erlinge, Jonas Andersson, Ole Fröbert, et al.
The Lancet (2024) Vol. 404, Iss. 10464, pp. 1750-1759
Closed Access | Times Cited: 6
Biodegradable Stents in the Treatment of Arterial Stenosis
Raşit Dinç, Evren Ekingen
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 532-532
Open Access
The Absorb GT1 Bioresorbable Vascular Scaffold System ― 5-Year Post-Market Surveillance Study in Japan ―
Masato Nakamura, Nobuaki Suzuki, Kenshi Fujii, et al.
Circulation Journal (2024) Vol. 88, Iss. 6, pp. 863-872
Open Access | Times Cited: 3
How to perform a successful drug‐coated balloon angioplasty? Tips and tricks
Sandeep Basavarajaiah, Harkaran Kalkat, Gurbir Bhatia, et al.
Catheterization and Cardiovascular Interventions (2023) Vol. 102, Iss. 7, pp. 1238-1257
Closed Access | Times Cited: 8
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART)
Michele Pighi, Fabrizio Tomai, Simone Fezzi, et al.
Clinical Research in Cardiology (2024) Vol. 113, Iss. 7, pp. 1017-1029
Closed Access | Times Cited: 2
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
David Erlinge, Jonas Andersson, Ole Fröbert, et al.
American Heart Journal (2024) Vol. 277, pp. 1-10
Open Access | Times Cited: 2
Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis
Javier Cuesta, Marı́a José Pérez-Vizcayno, Bruno García del Blanco, et al.
КАРДИОЛОГИЯ УЗБЕКИСТАНА (2024) Vol. 17, Iss. 15, pp. 1825-1836
Closed Access | Times Cited: 2
Bioresorbable Scaffolds
Patrick W. Serruys, Pruthvi C. Revaiah, Yoshinobu Onuma
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 3, pp. 196-199
Open Access | Times Cited: 5
Bioresorbable Scaffolds ― A Ray of Hope in the Darkness ―
Takashi Muramatsu, Yoshinobu Onuma, Patrick W. Serruys
Circulation Journal (2024) Vol. 88, Iss. 6, pp. 873-875
Open Access | Times Cited: 1
Potential of Biodegradable Stents in Congenital Heart Disease
Naoyuki Hatayama, Tatsuya Watanabe, Satoshi Yuhara, et al.
Deleted Journal (2024)
Closed Access | Times Cited: 1
Challenges and Advances in Interventional Cardiology for Coronary Artery Disease Management
Leslie Marisol Lugo‐Gavidia, Marco A. Alcocer‐Gamba, Araceli Martínez-Cervantes
Medicina (2024) Vol. 60, Iss. 8, pp. 1323-1323
Open Access | Times Cited: 1
Ten-year clinical outcomes of everolimus- and biolimus-eluting coronary stents vs. everolimus-eluting bioresorbable vascular scaffolds—insights from the EVERBIO-2 trial
Samir Bengueddache, Malica Cook, Sonja Lehmann, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Current situation and overview of resorbable magnesium scaffolds: a perspective for overcoming the remaining issues of polymeric bioresorbable scaffold
Masaru Seguchi, Kenichi Sakakura, Yousuke Taniguchi, et al.
Cardiovascular Intervention and Therapeutics (2024)
Closed Access | Times Cited: 1
Is it time for a retinoic acid-eluting stent or retinoic acid-coated balloon? Insights from experimental studies of systemic and local delivery of retinoids
Ιωάννα Σαμαρά, Anargyros N. Moulas, Georgia S. Karanasiou, et al.
Hellenic Journal of Cardiology (2023) Vol. 76, pp. 75-87
Open Access | Times Cited: 2
Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial
Lei Song, Changdong Guan, Mengyue Yu, et al.
American Heart Journal (2024) Vol. 275, pp. 53-61
Closed Access
Editorial: Reviews in bioresorbable scaffold
Vikrant Rai, Juan F. Iglesias, Matthias Bossard, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Five-Year Outcomes of Bioresorbable Stent Therapy for Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Feifei Yang, Hui Song, Wei-bin Qin, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 7, pp. 238-238
Open Access
Long-term outcomes following bioresorbable vascular scaffolds
Kotaro Miyashita, Kai Ninomiya, Akihiro Tobe, et al.
Expert Review of Cardiovascular Therapy (2024) Vol. 22, Iss. 8, pp. 391-407
Closed Access
Bioresorbable Scaffold Use in Coronary Chronic Total Occlusions: A Long-Term, Single-Center Follow-Up Study
Dace Sondore, Ieva Briede, M. Linde, et al.
Medicina (2024) Vol. 60, Iss. 8, pp. 1233-1233
Open Access
Advances in Technology and Technique in Percutaneous Coronary Intervention: A Clinical Review
Yuichi Saito, Yoshio Kobayashi
Internal Medicine (2024)
Open Access
First experience of implantation of a new-generation bioresorbable stent in a young patient with coronary artery disease: a case report
D. K. Vasiliev, N. A. Arablinskiy, F. B. Shukurov, et al.
CARDIOVASCULAR THERAPY AND PREVENTION (2024) Vol. 23, Iss. 9, pp. 4196-4196
Open Access
Page 1 - Next Page

Scroll to top